Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 10:37 PM
Study NCT ID:
NCT05957367
Status:
RECRUITING
Last Update Posted:
2025-10-22
First Post:
2023-07-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Sponsor:
Deciphera Pharmaceuticals, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-14
First Submit QC Date:
None
Study First Post Date:
2023-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-21
Last Update Post Date:
2025-10-22
Last Update Post Date Type:
ESTIMATED